Encision Inc. (ECIA)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.29 Million USD | 44.37% |
| 2023 | 894 Thousand USD | 338.24% |
| 2022 | 204 Thousand USD | -61.44% |
| 2021 | 529 Thousand USD | -62.43% |
| 2020 | 1.4 Million USD | 809.22% |
| 2019 | -198.52 Thousand USD | -89.3% |
| 2018 | -104.87 Thousand USD | -145.6% |
| 2017 | 230 Thousand USD | 85.48% |
| 2016 | 124 Thousand USD | 231.91% |
| 2015 | -94 Thousand USD | 94.0% |
| 2014 | -1.56 Million USD | -1144.37% |
| 2013 | -126 Thousand USD | 77.69% |
| 2012 | -564.67 Thousand USD | -279.27% |
| 2011 | 314.99 Thousand USD | 33.47% |
| 2010 | 236 Thousand USD | 122.05% |
| 2009 | 106.28 Thousand USD | -80.13% |
| 2008 | 535 Thousand USD | 222.59% |
| 2007 | -436.4 Thousand USD | 51.59% |
| 2006 | -901.54 Thousand USD | 38.77% |
| 2005 | -1.47 Million USD | -11.12% |
| 2004 | -1.32 Million USD | -126.28% |
| 2003 | -585.55 Thousand USD | -16.88% |
| 2002 | -500.98 Thousand USD | 36.7% |
| 2001 | -791.41 Thousand USD | -77.26% |
| 2000 | -446.47 Thousand USD | 62.45% |
| 1999 | -1.18 Million USD | 52.92% |
| 1998 | -2.52 Million USD | -379.12% |
| 1997 | -527.01 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.5 Million USD | 75.67% |
| 2024 Q1 | 855 Thousand USD | -4.36% |
| 2024 FY | 1.29 Million USD | 44.37% |
| 2024 Q3 | 1.32 Million USD | -11.51% |
| 2024 Q4 | 1.29 Million USD | -2.89% |
| 2023 Q3 | 857 Thousand USD | 51.75% |
| 2023 Q1 | 244 Thousand USD | 19.61% |
| 2023 FY | 894 Thousand USD | 338.24% |
| 2023 Q4 | 894 Thousand USD | 4.32% |
| 2023 Q2 | 564.74 Thousand USD | 131.45% |
| 2022 Q1 | 599 Thousand USD | 13.23% |
| 2022 Q2 | -288 Thousand USD | -148.08% |
| 2022 Q3 | -189 Thousand USD | 34.38% |
| 2022 Q4 | 204 Thousand USD | 207.94% |
| 2022 FY | 204 Thousand USD | -61.44% |
| 2021 FY | 529 Thousand USD | -62.43% |
| 2021 Q2 | 1.53 Million USD | -0.39% |
| 2021 Q1 | 1.53 Million USD | 9.09% |
| 2021 Q4 | 529 Thousand USD | -11.69% |
| 2021 Q3 | 599 Thousand USD | -60.85% |
| 2020 Q4 | 1.4 Million USD | 8.98% |
| 2020 Q2 | 1.17 Million USD | -5.69% |
| 2020 Q3 | 1.29 Million USD | 9.77% |
| 2020 FY | 1.4 Million USD | 809.22% |
| 2020 Q1 | 1.24 Million USD | 728.63% |
| 2019 Q4 | -198.52 Thousand USD | 60.56% |
| 2019 Q3 | -503.31 Thousand USD | -333.06% |
| 2019 Q1 | 34 Thousand USD | 132.42% |
| 2019 FY | -198.52 Thousand USD | -89.3% |
| 2019 Q2 | -116.22 Thousand USD | -441.83% |
| 2018 Q1 | 128 Thousand USD | -44.35% |
| 2018 Q3 | -195.27 Thousand USD | -88.34% |
| 2018 Q4 | -104.87 Thousand USD | 46.3% |
| 2018 FY | -104.87 Thousand USD | -145.6% |
| 2018 Q2 | -103.68 Thousand USD | -181.0% |
| 2017 Q2 | 336 Thousand USD | 15.46% |
| 2017 Q3 | 220 Thousand USD | -34.52% |
| 2017 FY | 230 Thousand USD | 85.48% |
| 2017 Q1 | 291 Thousand USD | 134.68% |
| 2017 Q4 | 230 Thousand USD | 4.55% |
| 2016 Q4 | 124 Thousand USD | -47.68% |
| 2016 FY | 124 Thousand USD | 231.91% |
| 2016 Q1 | 32 Thousand USD | 134.04% |
| 2016 Q2 | 3000.00 USD | -90.63% |
| 2016 Q3 | 237 Thousand USD | 7800.0% |
| 2015 Q4 | -94 Thousand USD | 81.01% |
| 2015 FY | -94 Thousand USD | 94.0% |
| 2015 Q2 | -894 Thousand USD | 8.96% |
| 2015 Q1 | -982 Thousand USD | 37.37% |
| 2015 Q3 | -495 Thousand USD | 44.63% |
| 2014 Q1 | 800 Thousand USD | 734.92% |
| 2014 FY | -1.56 Million USD | -1144.37% |
| 2014 Q4 | -1.56 Million USD | -19.78% |
| 2014 Q3 | -1.3 Million USD | -306.14% |
| 2014 Q2 | 635 Thousand USD | -20.63% |
| 2013 Q4 | -126 Thousand USD | 73.36% |
| 2013 Q2 | -558 Thousand USD | -20.52% |
| 2013 Q1 | -463 Thousand USD | 18.01% |
| 2013 FY | -126 Thousand USD | 77.69% |
| 2013 Q3 | -473 Thousand USD | 15.23% |
| 2012 Q1 | 446.82 Thousand USD | 41.85% |
| 2012 Q4 | -564.67 Thousand USD | -175.29% |
| 2012 FY | -564.67 Thousand USD | -279.27% |
| 2012 Q2 | 675.88 Thousand USD | 51.26% |
| 2012 Q3 | 750.01 Thousand USD | 10.97% |
| 2011 Q4 | 314.99 Thousand USD | -19.82% |
| 2011 Q3 | 392.86 Thousand USD | -7.83% |
| 2011 FY | 314.99 Thousand USD | 33.47% |
| 2011 Q2 | 426.23 Thousand USD | -13.93% |
| 2011 Q1 | 495.21 Thousand USD | 109.6% |
| 2010 Q1 | 149.46 Thousand USD | 40.63% |
| 2010 Q3 | 228.41 Thousand USD | 406.58% |
| 2010 FY | 236 Thousand USD | 122.05% |
| 2010 Q2 | 45.09 Thousand USD | -69.83% |
| 2010 Q4 | 236.26 Thousand USD | 3.44% |
| 2009 Q2 | 204.97 Thousand USD | -47.01% |
| 2009 Q4 | 106.28 Thousand USD | -16.02% |
| 2009 Q3 | 126.56 Thousand USD | -38.25% |
| 2009 FY | 106.28 Thousand USD | -80.13% |
| 2009 Q1 | 386.82 Thousand USD | -27.7% |
| 2008 Q1 | -88.44 Thousand USD | 79.73% |
| 2008 FY | 535 Thousand USD | 222.59% |
| 2008 Q3 | 181.09 Thousand USD | -17.9% |
| 2008 Q4 | 535 Thousand USD | 195.43% |
| 2008 Q2 | 220.58 Thousand USD | 349.4% |
| 2007 FY | -436.4 Thousand USD | 51.59% |
| 2007 Q3 | -1.14 Million USD | 1.68% |
| 2007 Q1 | -1.09 Million USD | -21.85% |
| 2007 Q4 | -436.4 Thousand USD | 62.05% |
| 2007 Q2 | -1.16 Million USD | -6.47% |
| 2006 Q4 | -901.54 Thousand USD | -24.21% |
| 2006 Q1 | -1.11 Million USD | 24.29% |
| 2006 Q3 | -725.84 Thousand USD | 12.78% |
| 2006 Q2 | -832.18 Thousand USD | 25.35% |
| 2006 FY | -901.54 Thousand USD | 38.77% |
| 2005 FY | -1.47 Million USD | -11.12% |
| 2005 Q3 | -1.26 Million USD | 9.35% |
| 2005 Q1 | -1.38 Million USD | -4.3% |
| 2005 Q4 | -1.47 Million USD | -16.14% |
| 2005 Q2 | -1.39 Million USD | -1.2% |
| 2004 Q2 | -1.35 Million USD | -186.56% |
| 2004 FY | -1.32 Million USD | -126.28% |
| 2004 Q3 | -1.19 Million USD | 11.98% |
| 2004 Q4 | -1.32 Million USD | -11.09% |
| 2004 Q1 | -472.88 Thousand USD | 19.24% |
| 2003 Q2 | -597.72 Thousand USD | -21.97% |
| 2003 FY | -585.55 Thousand USD | -16.88% |
| 2003 Q4 | -585.55 Thousand USD | 12.65% |
| 2003 Q3 | -670.33 Thousand USD | -12.15% |
| 2003 Q1 | -490.06 Thousand USD | 2.18% |
| 2002 Q1 | -838.44 Thousand USD | -5.94% |
| 2002 Q2 | -833.56 Thousand USD | 0.58% |
| 2002 FY | -500.98 Thousand USD | 36.7% |
| 2002 Q4 | -500.98 Thousand USD | 19.27% |
| 2002 Q3 | -620.53 Thousand USD | 25.56% |
| 2001 Q3 | -252.92 Thousand USD | 56.1% |
| 2001 FY | -791.41 Thousand USD | -77.26% |
| 2001 Q2 | -576.15 Thousand USD | 45.41% |
| 2001 Q4 | -791.41 Thousand USD | -212.9% |
| 2001 Q1 | -1.05 Million USD | -136.4% |
| 2000 Q4 | -446.47 Thousand USD | 49.43% |
| 2000 Q3 | -882.86 Thousand USD | 0.0% |
| 2000 FY | -446.47 Thousand USD | 62.45% |
| 1999 FY | -1.18 Million USD | 52.92% |
| 1998 FY | -2.52 Million USD | -379.12% |
| 1997 FY | -527.01 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -169.101% |
| Ansell Limited | -54.99 Million USD | 102.347% |
| Ansell Limited | -55.1 Million USD | 102.342% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 103.537% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 1328.038% |
| Psykey, Inc. | 634.59 Thousand USD | -103.389% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.892% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.893% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 44.095% |
| Innovative MedTech Inc. | 1.76 Million USD | 26.862% |
| LifePoint, Inc. | -3.26 Million USD | 139.543% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 73.682% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 40.301% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 3080.54% |
| Reflect Scientific, Inc. | -1.03 Million USD | 224.668% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.834% |
| Sector 10, Inc. | 163 Thousand USD | -691.836% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.309% |
| SheerVision, Inc. | 57.34 Thousand USD | -2150.594% |
| United Health Products, Inc. | 660.56 Thousand USD | -95.391% |
| Vasamed, Inc. | 22.12 Thousand USD | -5734.432% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 50.947% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -67.128% |